Velcade Finally Approved, But Disappointment For Myeloma Patients As NICE Move The Goalposts, UK
Friday, August 31st, 2007
In response to the recent final decision by NICE on the use of Velcade for cancer patients with myeloma, the bone marrow cancer, charities Myeloma UK, Cancerbackup and Leukaemia CARE issue the following response:
The long awaited decision on Velcade has resulted in a positive approval of the treatment, but many patients will now be ineligible to receive it after a change in the guidance since the preliminary ruling in June. (Read content ‘Velcade Finally Approved, But Disappointment For Myeloma Patients As NICE Move The Goalposts, UK’…)